GYRE THERAPEUTICS, INC. (GYRE) › Shares OutstandingGYRE THERAPEUTICS, INC. (GYRE) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2010: 28.87M2011: 33.38M2012: 33.62M2013: 33.72M2014: 370.9K2015: 762.0K2016: 801.8K2017: 6.08M2018: 11.95M2019: 12.04M2020: 22.10M2021: 31.41M2022: 63.59M2023: 76.60M2024: 86.31M2025: 91.31M91.31M2010Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202591.31M+5.8%202486.31M+12.7%202376.60M+20.5%202263.59M+102.4%202131.41M+42.1%202022.10M+83.5%201912.04M+0.7%201811.95M+96.6%20176.08M+658.5%2016801.8K+5.2%2015762.0K+105.4%2014370.9K-98.9%201333.72M+0.3%201233.62M+0.7%201133.38M+15.6%201028.87M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share